Catch up on stories from the past week (and beyond) at the Slashdot story archive

 



Forgot your password?
typodupeerror

Slashdot videos: Now with more Slashdot!

  • View

  • Discuss

  • Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).

×
Biotech

+ - Avastin Failure Highlights Drug Research Problems

Submitted by
SoyChemist
SoyChemist writes "When an FDA committee decided that blockbuster oncology drug Avastin should not be used to treat breast cancer because the risks outweigh the benefits, shares of Genentech stock plummeted. Rather than reciting financial figures, Business Week reporter Arlene Weintraub took a step back and painted a detailed picture of how the biotech company is trying to skirt major industry problems within the field of autoimmune disease research. Wired Science provided further analysis, explaining the importance increasing the variety of avoiding me too drugs, not rushing research, and using a personalized medicine approach."
This discussion was created for logged-in users only, but now has been archived. No new comments can be posted.

Avastin Failure Highlights Drug Research Problems

Comments Filter:

"A child is a person who can't understand why someone would give away a perfectly good kitten." -- Doug Larson

Working...